Sex differences in substance use disorders: focus on side effects

Addiction Biology

Volumn 21, Issue 5, 2016, Pages 1030-1042

  Agabio, Roberta ^a   Campesi, Ilaria ^b,c   Pisanu, Claudia ^a   Gessa, Gian Luigi ^a,d   Franconi, Flavia ^b,c,e  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

^c UNIVERSITY OF SASSARI   (Italy)

^d CNR   (Italy)

^e Assessorato alle Politiche per la Persona   (Italy)

Author keywords

Alcohol; cocaine; heroin; marijuana; nicotine; sex differences

Indexed keywords

ALCOHOL; AMFEBUTAMONE; BUPRENORPHINE; CANNABIS; COCAINE; DIAMORPHINE; METHADONE; NALTREXONE; NICOTINE;

ALCOHOL ABUSE; ALCOHOL INTOXICATION; ALCOHOL LIVER DISEASE; ALCOHOLIC CARDIOMYOPATHY; ALCOHOLISM; ARTICLE; BODY WEIGHT; BRAIN DAMAGE; CANNABIS ADDICTION; DRUG SAFETY; HEROIN DEPENDENCE; HUMAN; ISCHEMIC HEART DISEASE; LUNG DISEASE; MORTALITY; MYOPATHY; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SUBSTANCE ABUSE; SUBSTITUTION THERAPY; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME;

EID: 84980411185     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/adb.12395     Document Type: Article

References (74)

1. Agabio R, Pani PP, Preti A, Gessa GL, Franconi F (2016) Efficacy of medications approved for the treatment of alcohol dependence and alcohol withdrawal syndrome in female patients: a descriptive review. Eur Addict Res 22:1–16.
2. Arnedt JT, Rohsenow DJ, Almeida AB, Hunt SK, Gokhale M, Gottlieb DJ, Howland J (2011) Sleep following alcohol intoxication in healthy, young adults: effects of sex and family history of alcoholism. Alcohol Clin Exp Res 35:870–878.
3. Baker TB, Piper ME, Stein JH, Smith SS, Bolt DM, Fraser DL, Fiore MC (2016) Effects of nicotine patch vs varenicline vs combination nicotine replacement therapy on smoking cessation at 26 weeks: a randomized clinical trial. JAMA 315:371–379.
4. Becker JB, Hu M (2008) Sex differences in drug abuse. Front Neuroendocrinol 29:36–47.
5. Becker JB, Perry AN, Westenbroek C (2012) Sex differences in the neural mechanisms mediating addiction: a new synthesis and hypothesis. Biol Sex Differ 3:14.
6. Benowitz NL, Lessov-Schlaggar CN, Swan GE, Jacob P 3rd (2006) Female sex and oral contraceptive use accelerate nicotine metabolism. Clin Pharmacol Ther 79:480–488.
7. Benowitz NL, Hukkanen J, Jacob P 3rd (2009) Nicotine chemistry, metabolism, kinetics and biomarkers. Handb Exp Pharmacol 192:29–60.
8. Bobzean SA, DeNobrega AK, Perrotti LI (2014) Sex differences in the neurobiology of drug addiction. Exp Neurol 259:64–74.
9. Camlin NJ, McLaughlin EA, Holt JE (2014) Through the smoke: use of in vivo and in vitro cigarette smoking models to elucidate its effect on female fertility. Toxicol Appl Pharmacol 281:266–275.
10. Chang KC, Huang CL, Liang HY, Chang SS, Wang YC, Liang WM, Lane HY, Chen CH, Stephen Huang SK (2012) Gender-specific differences in susceptibility to low-dose methadone-associated QTc prolongation in patients with heroin dependence. J Cardiovasc Electrophysiol 23:527–533.
11. Chapman SL, Wu LT (2014) Suicide and substance use among female veterans: a need for research. Drug Alcohol Depend 136:1–10.
12. Coleman T, Chamberlain C, Davey MA, Cooper SE, Leonardi-Bee J (2012) Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev 9:CD010078.
13. Connett JE, Murray RP, Buist AS, Wise RA, Bailey WC, Lindgren PG, Owens GR (2003) Changes in smoking status affect women more than men: results of the Lung Health Study. Am J Epidemiol 157:973–979.
14. Conway KP, Compton W, Stinson FS, Grant BF (2006) Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 67:247–257.
15. Cosgrove KP, Wang S, Kim SJ, McGovern E, Nabulsi N, Gao H, Labaree D, Tagare HD, Sullivan JM, Morris ED (2014) Sex differences in the brain's dopamine signature of cigarette smoking. J Neurosci 34:16851–16855.
16. Crane NA, Schuster RM, Fusar-Poli P, Gonzalez R (2013) Effects of cannabis on neurocognitive functioning: recent advances, neurodevelopmental influences, and sex differences. Neuropsychol Rev 23:117–137.
17. Darke S, Ross J (2002) Suicide among heroin users: rates, risk factors and methods. Addiction 97:1383–1394.
18. Degenhardt L, Bucello C, Mathers B, Briegleb C, Ali H, Hickman M, McLaren J (2011) Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction 106:32–51.
19. Des Jarlais DC, Feelemyer JP, Modi SN, Arasteh K, Hagan H (2012) Are females who inject drugs at higher risk for HIV infection than males who inject drugs: an international systematic review of high seroprevalence areas. Drug Alcohol Depend 124:95–107.
20. DeVito EE, Herman AI, Waters AJ, Valentine GW, Sofuoglu M (2014) Subjective, physiological, and cognitive responses to intravenous nicotine: effects of sex and menstrual cycle phase. Neuropsychopharmacology 39:1431–1440.
21. Di Castelnuovo A, Costanzo S, Bagnardi V, Donati MB, Iacoviello L, de Gaetano G (2006) Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies. Arch Intern Med 166:2437–2445.
22. Erol A, Karpyak VM (2015) Sex and gender-related differences in alcohol use and its consequences: contemporary knowledge and future research considerations. Drug Alcohol Depend 156:1–13.
23. Farley AC, Hajek P, Lycett D, Aveyard P (2012) Interventions for preventing weight gain after smoking cessation. Cochrane Database Syst Rev 1:CD006219.
24. FDA (2015) FDA Drug Safety Communication: FDA updates label for stop smoking drug Chantix (varenicline) to include potential alcohol interaction, rare risk of seizures, and studies of side effects on mood, behavior, or thinking. U.S. Food and Drug Administration.
25. Franconi F, Campesi I (2014) Sex and gender influences on pharmacological response: an overview. Expert Rev Clin Pharmacol 7:469–485.
26. Franconi F, Campesi I, Occhioni S, Antonini P, Murphy MF (2012) Sex and gender in adverse drug events, addiction, and placebo. Handb Exp Pharmacol 214:107–126.
27. de la Fuente L, Molist G, Espelt A, Barrio G, Guitart A, Bravo MJ, Brugal MT (2014) Mortality risk factors and excess mortality in a cohort of cocaine users admitted to drug treatment in Spain. J Subst Abuse Treat 46:219–226.
28. Gorzalka BB, Hill MN, Chang SC (2010) Male-female differences in the effects of cannabinoids on sexual behavior and gonadal hormone function. Horm Behav 58:91–99.
29. Greenfield SF, Back SE, Lawson K, Brady KT (2010) Substance abuse in women. Psychiatr Clin North Am 33:339–355.
30. Heberlein A, Leggio L, Stichtenoth D, Hillemacher T (2012) The treatment of alcohol and opioid dependence in pregnant women. Curr Opin Psychiatry 25:559–564.
31. Hernandez-Avila CA, Rounsaville BJ, Kranzler HR (2004) Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatment. Drug Alcohol Depend 74:265–272.
32. Hukkanen J, Gourlay SG, Kenkare S, Benowitz NL (2005) Influence of menstrual cycle on cytochrome P450 2A6 activity and cardiovascular effects of nicotine. Clin Pharmacol Ther 77:159–169.
33. Huxley RR, Woodward M (2011) Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet 378:1297–1305.
34. Ilett KF, Hale TW, Page-Sharp M, Kristensen JH, Kohan R, Hackett LP (2003) Use of nicotine patches in breast-feeding mothers: transfer of nicotine and cotinine into human milk. Clin Pharmacol Ther 74:516–524.
35. Iversen J, Wand H, Gonnermann A, Maher L (2010) Gender differences in hepatitis C antibody prevalence and risk behaviours amongst people who inject drugs in Australia 1998–2008. Int J Drug Policy 21:471–476.
36. Jin M, Cai S, Guo J, Zhu Y, Li M, Yu Y, Zhang S, Chen K (2013) Alcohol drinking and all cancer mortality: a meta-analysis. Ann Oncol 24:807–816.
37. Keyes KM, Martins SS, Blanco C, Hasin DS (2010) Telescoping and gender differences in alcohol dependence: new evidence from two national surveys. Am J Psychiatry 167:969–976.
38. Khan SS, Secades-Villa R, Okuda M, Wang S, Perez-Fuentes G, Kerridge BT, Blanco C (2013) Gender differences in cannabis use disorders: results from the National Epidemiologic Survey of Alcohol and Related Conditions. Drug Alcohol Depend 130:101–108.
39. Kuehn BM (2013) FDA warning: driving may be impaired the morning following sleeping pill use. JAMA 309:645–646.
40. Large M, Sharma S, Compton MT, Slade T, Nielssen O (2011) Cannabis use and earlier onset of psychosis: a systematic meta-analysis. Actarch Gen Psychiatry 68:555–561.
41. Lenz B, Muller CP, Stoessel C, Sperling W, Biermann T, Hillemacher T, Bleich S, Kornhuber J (2012) Sex hormone activity in alcohol addiction: integrating organizational and activational effects. Prog Neurobiol 96:136–163.
42. Litten RZ, Egli M, Heilig M, Cui C, Fertig JB, Ryan ML, Falk DE, Moss H, Huebner R, Noronha A (2012) Medications development to treat alcohol dependence: a vision for the next decade. Addict Biol 17:513–527.
43. Lukas SE, Sholar M, Lundahl LH, Lamas X, Kouri E, Wines JD, Kragie L, Mendelson JH (1996) Sex differences in plasma cocaine levels and subjective effects after acute cocaine administration in human volunteers. Psychopharmacology (Berl) 125:346–354.
44. Lynch WJ, Kalayasiri R, Sughondhabirom A, Pittman B, Coric V, Morgan PT, Malison RT (2008) Subjective responses and cardiovascular effects of self-administered cocaine in cocaine-abusing men and women. Addict Biol 13:403–410.
45. Lyoo IK, Streeter CC, Ahn KH, Lee HK, Pollack MH, Silveri MM, Nassar L, Levin JM, Sarid-Segal O, Ciraulo DA, Renshaw PF, Kaufman MJ (2004) White matter hyperintensities in subjects with cocaine and opiate dependence and healthy comparison subjects. Psychiatry Res 131:135–145.
46. Mahoney JJ 3rd, Hawkins RY, De La Garza R 2nd, Kalechstein AD, Newton TF (2010) Relationship between gender and psychotic symptoms in cocaine-dependent and methamphetamine-dependent participants. Gend Med 7:414–421.
47. Mendelson JH, Mello NK, Sholar MB, Siegel AJ, Kaufman MJ, Levin JM, Renshaw PF, Cohen BM (1999) Cocaine pharmacokinetics in men and in women during the follicular and luteal phases of the menstrual cycle. Neuropsychopharmacology 21:294–303.
48. Moody DE, Fang WB, Morrison J, McCance-Katz E (2011) Gender differences in pharmacokinetics of maintenance dosed buprenorphine. Drug Alcohol Depend 118:479–483.
49. Mumenthaler MS, Taylor JL, O'Hara R, Yesavage JA (1999) Gender differences in moderate drinking effects. Alcohol Res Health 23:55–64.
50. Nielsen CH, Larsen A, Nielsen AL (2016) DNA methylation alterations in response to prenatal exposure of maternal cigarette smoking: a persistent epigenetic impact on health from maternal lifestyle? Arch Toxicol 90:231–245.
51. Nolen-Hoeksema S, Hilt L (2006) Possible contributors to the gender differences in alcohol use and problems. J Gen Psychol 133:357–374.
52. O'Brien CP (2011) Drug Addiction. In: Brunton LL, Chabner BA, Knollmann BC eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics, pp 650–668. McGraw-Hill, Medical Publishing Division: New York.
53. Origer A, Lopes da Costa S, Baumann M (2014) Opiate- and cocaine-related fatal overdoses in Luxembourg from 1985 to 2011: a study on gender differences. Eur Addict Res 20:87–93.
54. Perkins KA (2001) Smoking cessation in women. Special considerations. CNS Drugs 15:391–411.
55. Peters SA, Huxley RR, Woodward M (2013) Smoking as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 81 cohorts, including 3,980,359 individuals and 42,401 strokes. Stroke 44:2821–2828.
56. Peters SA, Huxley RR, Woodward M (2014) Do smoking habits differ between women and men in contemporary Western populations? Evidence from half a million people in the UK Biobank study. BMJ Open 4:e005663.
57. Pleym H, Spigset O, Kharasch ED, Dale O (2003) Gender differences in drug effects: implications for anesthesiologists. Acta Anaesthesiol Scand 47:241–259.
58. Ramchandani VA, Bosron WF, Li TK (2001) Research advances in ethanol metabolism. Pathol Biol (Paris) 49:676–682.
59. Rehm J, Taylor B, Mohapatra S, Irving H, Baliunas D, Patra J, Roerecke M (2010) Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis. Drug Alcohol Rev 29:437–445.
60. Roche DJ, King AC (2015) Sex differences in acute hormonal and subjective response to naltrexone: the impact of menstrual cycle phase. Psychoneuroendocrinology 52:59–71.
61. Roerecke M, Rehm J (2013) Alcohol use disorders and mortality: a systematic review and meta-analysis. Addiction 108:1562–1578.
62. Roswall N, Weiderpass E (2015) Alcohol as a risk factor for cancer: existing evidence in a global perspective. J Prev Med Public Health 48:1–9.
63. Sarkar DK (2015) Male germline transmits fetal alcohol epigenetic marks for multiple generations: a review. Addict Biol 21:23–34.
64. Sarton E, Romberg R, Dahan A (2003) Gender differences in morphine pharmacokinetics and dynamics. Adv Exp Med Biol 523:71–80.
65. Schuckit MA (2011) Ethanol and Methanol. In: Brunton LL, Chabner BA, Knollmann BC eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics, pp 628–647. McGraw-Hill, Medical Publishing Division: New York.
66. Schuckit MA, Smith TL, Trim RS, Kuperman S, Kramer J, Hesselbrock V, Bucholz KK, Nurnberger JI Jr, Hesselbrock M, Saunders G (2012) Sex differences in how a low sensitivity to alcohol relates to later heavy drinking. Drug Alcohol Rev 31:871–880.
67. Seitz HK, Egerer G, Simanowski UA, Waldherr R, Eckey R, Agarwal DP, Goedde HW, von Wartburg JP (1993) Human gastric alcohol dehydrogenase activity: effect of age, sex, and alcoholism. Gut 34:1433–1437.
68. Vassoler FM, Byrnes EM, Pierce RC (2014) The impact of exposure to addictive drugs on future generations: physiological and behavioral effects. Neuropharmacology 76:269–275.
69. Vergara-Moragues E, Araos Gomez P, Gonzalez-Saiz F, Rodriguez-Fonseca F (2014) Cocaine-induced psychotic symptoms in clinical setting. Psychiatry Res 217:115–120.
70. Wall ME, Sadler BM, Brine D, Taylor H, Perez-Reyes M (1983) Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women. Clin Pharmacol Ther 34:352–363.
71. Weinberger AH, Smith PH, Kaufman M, McKee SA (2014) Consideration of sex in clinical trials of transdermal nicotine patch: a systematic review. Exp Clin Psychopharmacol 22:373–383.
72. Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, Charlson FJ, Norman RE, Flaxman AD, Johns N, Burstein R, Murray CJ, Vos T (2013) Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet 382:1575–1586.
73. Yamamoto RT, Teter CJ, Barros TL, McCarthy E, Mileti C, Juliano T, Medeiros CL, Looby A, Maywalt MA, McNeil JF, Olson D, Mallya G, Lukas SE, Renshaw PF, Kaufman MJ (2007) Antiandrogen pretreatment alters cocaine pharmacokinetics in men. J Addict Med 1:198–204.
74. Zaazaa A, Bella AJ, Shamloul R (2013) Drug addiction and sexual dysfunction. Endocrinol Metab Clin North Am 42:585–592.